Drug Profile
Clonidine topical gel - BioDelivery Sciences International
Alternative Names: ARC-4558Latest Information Update: 31 Dec 2021
Price :
$50
*
At a glance
- Originator Arcion Therapeutics
- Developer BioDelivery Sciences International
- Class Analgesics; Anti-inflammatories; Antiglaucomas; Antimigraines; Behavioural disorder therapies; Centrally-acting antihypertensives; Chlorobenzenes; Imidazolines; Small molecules
- Mechanism of Action Adrenergic receptor antagonists; Alpha 2 adrenergic receptor agonists; Imidazoline receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetic neuropathies
Most Recent Events
- 01 Feb 2017 BioDelivery Sciences returns back worldwide licensing rights for clonidine topical gel to Arcion Therapeutics
- 13 Dec 2016 Discontinued - Phase-III for Diabetic neuropathies in USA due to lack of efficacy (Topical)
- 01 Nov 2016 BioDelivery Sciences completes a phase IIb trial for Diabetic neuropathy in USA (NCT02643251)